Zoetis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Zoetis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ZTS

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments. 

CEO
Kristin C. Peck
CEOKristin C. Peck
Employees
14,500
Employees14,500
Headquarters
Parsippany, New Jersey
HeadquartersParsippany, New Jersey
Founded
1952
Founded1952
Employees
14,500
Employees14,500

ZTS Key Statistics

Market cap
30.14B
Market cap30.14B
Price-Earnings ratio
12.14
Price-Earnings ratio12.14
Dividend yield
2.83%
Dividend yield2.83%
Average volume
8.62M
Average volume8.62M
High today
$73.75
High today$73.75
Low today
$71.00
Low today$71.00
Open price
$73.01
Open price$73.01
Volume
6.55M
Volume6.55M
52 Week high
$160.48
52 Week high$160.48
52 Week low
$71.00
52 Week low$71.00

Stock Snapshot

Zoetis(ZTS) stock is priced at $72.95, giving the company a market capitalization of 30.14B. It carries a P/E multiple of 12.14 and pays a dividend yield of 2.83%.

On 2026-08-17, Zoetis(ZTS) stock traded between a low of $71.00 and a high of $73.75. Shares are currently priced at $72.95, which is +2.7% above the low and -1.1% below the high.

The Zoetis(ZTS)'s current trading volume is 6.55M, compared to an average daily volume of 8.62M.

In the last year, Zoetis(ZTS) shares hit a 52-week high of $160.48 and a 52-week low of $71.00.

In the last year, Zoetis(ZTS) shares hit a 52-week high of $160.48 and a 52-week low of $71.00.

ZTS News

TipRanks 18h
FDA issues Zoetis Emergency Use Authorization for Simparica TRIO for screwworm

The U.S. Food and Drug Administration issued an Emergency Use Authorization for Simparica TRIO for the treatment of New World screwworm infestations in dogs and...

Simply Wall St 2d
Zoetis Dropped, So What Is Driving Attention Now?

Advertisement Emergency use authorization adds a new dimension to Simparica Trio Zoetis (ZTS) is back in focus after the U.S. Food and Drug Administration gra...

Zoetis Dropped, So What Is Driving Attention Now?
TipRanks 3d
Zoetis, EPAM, Dropbox, Trade Desk, Samsara Trending

Analysts are intrested in these 5 stocks: ( (ZTS) ), ( (EPAM) ), ( (DBX) ), ( (TTD) ) and ( (IOT) ). Here is a breakdown of their recent ratings and the rationa...

Analyst ratings

55%

of 20 ratings
Buy
45%
Hold
55%
Sell
0%

More ZTS News

Nasdaq 5d
Zoetis Q2 2026 Earnings Call Transcript

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...

Zoetis Q2 2026 Earnings Call Transcript

People also own

Based on the portfolios of people who own ZTS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.